Product Introduction:
Trivogo Tablet is a combination medication containing Voglibose (0.3 mg), Metformin Hydrochloride (500 mg), and Glimepiride (2 mg). It is used for the management of type 2 diabetes mellitus to control blood sugar levels by improving insulin sensitivity and decreasing glucose absorption.
Uses:
-
Management of type 2 diabetes mellitus
-
Helps control blood glucose levels
-
Used when diet and exercise alone are insufficient
Benefit:
-
Combination therapy targets blood sugar through multiple pathways
-
Helps reduce post-meal blood sugar spikes (Voglibose)
-
Improves insulin action and secretion (Metformin & Glimepiride)
-
Reduces risk of diabetes-related complications
Composition:
-
Voglibose 0.3 mg
-
Metformin Hydrochloride 500 mg
-
Glimepiride 2 mg
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Gastrointestinal discomfort (nausea, diarrhea)
-
Weight gain (possible)
-
Dizziness or headache
Safety Advice:
-
Take with meals to reduce gastrointestinal side effects
-
Monitor blood sugar regularly
-
Carry glucose tablets or snacks to treat hypoglycemia
-
Inform your doctor if pregnant, breastfeeding, or on other medications
-
Avoid alcohol while taking this medication
